Recently, RBP4 has been reported to act as a bridge between obesity and cancer cell metabolism, and serum RBP4 levels in patients with HPA breast cancer have been reported to be significantly higher than those in control patients [18]. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.